Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7c92124a491c7d15c28385198cd801d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ea3215d4ccba707b78c4cf9133da5d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
filingDate |
2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fee716468082d262e0cccf8eb541787 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5677cd48c40f1e7e76a8ff17bc431aec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b4db04886796ea69eb3003f0b6234d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4aaa17dd05dcc1522a5b0fb6c28c24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2eaaeb8f18b40aea57f9e70eaea07e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63b417fba617097c4372e7a3bdcf897f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c17f13c24d230350d436231119d10cf |
publicationDate |
2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020262847-A1 |
titleOfInvention |
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same |
abstract |
The novel xanthine compounds are capable of inhibiting tryptophan hydroxylases (TPH) involved in the biosynthesis of serotonin and are effective in influencing the serotonin level in the body. |
priorityDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |